🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Anika Therapeutics, Inc.

ANIK Healthcare
$13.23 $-0.05 (-0.38%)
Market Cap: $177.22 M
Gurus Holding
4
Popularity Rank
#2231
% of Shares Held
6.84%
Net Activity (Q3 2026)
-$3.34 M

Guru Ownership Trend

Guru Analysis for Anika Therapeutics, Inc. (ANIK)

Anika Therapeutics, Inc. (ANIK), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q3 2026, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $12.13 M.

Top institutional holders include Renaissance Technologies (RenTech) and Cliff Asness.

Institutional sentiment is currently Slightly Bearish. This is evidenced by a $3.34 M net outflow during the quarter.

Recent activity highlights Paul Tudor Jones who increased their stake by 47.5%. Conversely, Cliff Asness reduced exposure by 28.4%.

Key Holders

Top 5 by Value

Recent Activity Breakdown (Q3 2026)

+$225,500.28
Total Buy Value
New Buys 0
Additions 2
-$3.57 M
Total Sell Value
Reductions 2
Sold Out 0

Guru Consensus (Q3 2026)

Based on recent activity
Net Sellers
2
Net Buyers
2

FAQs for Anika Therapeutics, Inc. (ANIK)

Major holders include Renaissance Technologies (RenTech) ($9.02 M), Cliff Asness ($7.88 M), Paul Tudor Jones ($662,208). According to the latest reported data, 4 tracked investment managers collectively hold approximately 916,525 shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $3.34 M, with 2 managers increasing positions and 2 managers reducing holdings.

During the most recent reporting period, 2 managers trimmed their positions, while 0 fully exited ANIK. The total reported sell value was $3.57 M.

Yes, 0 managers opened new positions in ANIK, and 2 increased their existing holdings. The total reported buy value was $225,500.28.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.01% Reduce -4.7% 458,717 $9.02 M Q3 2026
0.00% Reduce -28.4% 400,986 $7.88 M Q3 2026
0.00% Add 47.5% 33,683 $662,208 Q3 2026
0.00% Add 2.8% 23,139 $454,913 Q3 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form